Evidence map›Paper›PMID 35012895›Full record

ArticleBiomaterials advances2022

Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.

Rayana L Bighetti-Trevisan, Luciana O Almeida, Larissa M S Castro-Raucci, Jonathan A R Gordon, Coralee E Tye, Gary S Stein, Jane B Lian, Janet L Stein, Adalberto L Rosa, Marcio M Beloti

Open access · greenAbstract read
In one paragraph

Article in Biomaterials advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bone Regeneration and Repair Materials.Journal of functional biomaterials · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Rayana L Bighetti-TrevisanBone Research Lab, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Luciana O AlmeidaBone Research Lab, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Larissa M S Castro-RaucciSchool of Dentistry, University of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
Jonathan A R GordonDepartment of Biochemistry and Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Coralee E TyeDepartment of Biochemistry and Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Gary S SteinDepartment of Biochemistry and Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Jane B LianDepartment of Biochemistry and Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Janet L SteinDepartment of Biochemistry and Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Adalberto L RosaBone Research Lab, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Marcio M BelotiBone Research Lab, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: mmbeloti@usp.br.
University of Vermont · USUniversidade de São Paulo · BRUniversidade de Ribeirão Preto · BR

Funding

CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
Chromatin Organization Regulates OsteogenesisR01DE029311 · NIDCR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LIAN, JANE B., STEIN, GARY S. · 2020 to 2024
$2.5M
NIAMS NIH HHS R01 AR039588NIDCR NIH HHS R01 DE029311
6 · The paper itself

Abstract

The bone remodeling process is crucial for titanium (Ti) osseointegration and involves the crosstalk between osteoclasts and osteoblasts. Considering the high osteogenic potential of Ti with nanotopography (Ti Nano) and that osteoclasts inhibit osteoblast differentiation, we hypothesized that nanotopography attenuate the osteoclast-induced disruption of osteoblast differentiation. Osteoblasts were co-cultured with osteoclasts on Ti Nano and Ti Control and non-co-cultured osteoblasts were used as control. Gene expression analysis using RNAseq showed that osteoclasts downregulated the expression of osteoblast marker genes and upregulated genes related to histone modification and chromatin organization in osteoblasts grown on both Ti surfaces. Osteoclasts also inhibited the mRNA and protein expression of osteoblast markers, and such effect was attenuated by Ti Nano. Also, osteoclasts increased the protein expression of H3K9me2, H3K27me3 and EZH2 in osteoblasts grown on both Ti surfaces. ChIP assay revealed that osteoclasts increased accumulation of H3K27me3 that represses the promoter regions of Runx2 and Alpl in osteoblasts grown on Ti Control, which was reduced by Ti Nano. In conclusion, these data show that despite osteoclast inhibition of osteoblasts grown on both Ti Control and Ti Nano, the nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by preventing the increase of H3K27me3 accumulation that represses the promoter regions of some key osteoblast marker genes. These findings highlight the epigenetic mechanisms triggered by nanotopography to protect osteoblasts from the deleterious effects of osteoclasts, which modulate the process of bone remodeling and may benefit the osseointegration of Ti implants.

Indexed as

OsteoclastsTitaniumHistonesMethylationOsteoblastsSurface PropertiesHistonesTitaniumHistoneNanotopographyOsteoblastOsteoclastTitanium

Identifiers

PMID35012895
PMCPMC9098699
OpenAlexW3213433987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.